The enhancement of recombinant antibody production in Chinese Hamster Ovary (CHOK1) cells is a crucial aspect of biopharmaceutical development. To maximize yield, various methods are employed, including genetic engineering of the host cells and optimization of media conditions. Moreover, utilization of advanced production systems can significantl